Growing Diagnostic Capabilities CombiMatrix has a strong focus on expanding its cytogenomic testing services, including launching SNP microarray testing for intrauterine fetal demise and developing preimplantation genetic testing techniques. This presents opportunities to promote advanced genetic diagnostic solutions to reproductive health clinics and OB-GYN practices.

Specialized Market Focus With a niche in prenatal, miscarriage, and pediatric genetic diagnosis, CombiMatrix serves a targeted medical segment. Business development efforts could target fertility clinics, genetic counseling centers, and pediatric specialists looking for precise and reliable cytogenomic testing options.

Strategic Industry Positioning Operating with a revenue range between $10 million and $25 million and being part of a competitive landscape with large players like QIAGEN and Illumina, there is an opportunity to position specialized services that address unmet needs in niche genetic diagnostics, especially in prenatal and pediatric applications.

Digital Engagement Opportunities Utilizing digital marketing tools such as Google Analytics and HubSpot indicates an investment in online outreach. Expanding educational content, webinars, and targeted campaigns focused on healthcare providers can increase awareness and adoption of CombiMatrix’s testing services.